Tag Archives: Metastatic

Breast Cancer Spreads More Aggressively at Night, Startling New Study Finds

When people with metastatic breast cancer close their eyes at night, their cancer awakes and starts to spread. 

That’s the striking finding from a paper published in Nature this week that overturns the assumption that breast cancer metastasis happens at the same rate around the clock.  

 

The result may change the way that doctors collect blood samples from people with cancer in the future, the researchers say. 

“In our view, these findings may indicate the need for healthcare professionals to systematically record the time at which they perform biopsies,” says senior author Nicola Aceto, a professor of molecular oncology at ETH Zurich.

“It may help to make the data truly comparable.”

Researchers first stumbled across this topic when they noticed an unexplained difference in the number of circulating tumor cells in samples analyzed at different times of the day.  

“Some of my colleagues work early in the morning or late in the evening; sometimes they’ll also analyze blood at unusual hours,” Aceto says. 

Mice that seemed to have a much higher number of circulating cancer cells than humans provided another clue: Mice sleep during the day when blood samples are most often taken. 

To investigate what was going on, the Swiss researchers studied 30 women with breast cancer (21 patients with early breast cancer that had not metastasized and nine patients with stage IV metastatic disease). 

 

They found “a striking and unexpected pattern”: Most circulating tumor cells (78.3 percent) were found in blood samples that were taken at nighttime while a much lower amount was found in daytime samples.

When the researchers injected mice with breast cancer cells and took blood samples during the day, they found the same result. Circulating tumor cells were much higher when the mouse was at rest. 

Interestingly, the cancer cells collected during the rest period were “highly prone to metastasize, whereas circulating tumor cells generated during the active phase are devoid of metastatic ability”, the researchers said. 

Genetic analysis revealed that tumor cells taken from mice and humans at rest had upregulated their expression of mitotic genes. This makes them better at metastasizing as mitotic genes control cell division.

The researchers ran experiments where they gave some mice jet lag by changing the light-dark routine. Messing with the circadian rhythm led to a massive decrease in the concentration of circulating tumor cells in mice. 

In another experiment, the researchers tested whether giving the mice hormones that were similar to those found in the body when mice are awake would affect the number of circulating tumor cells when the mouse was at rest. 

 

They injected mice with testosterone, insulin (a hormone that makes it possible to turn sugar into energy), and dexamethasone (a synthetic chemical that acts like cortisol, the stress hormone). 

The researchers found a “marked reduction” in the number of circulating tumor cells in a blood sample taken during the rest period (when the tumor would normally be most aggressive).

“Our research shows that the escape of circulating cancer cells from the original tumor is controlled by hormones such as melatonin, which determine our rhythms of day and night,” says Zoi Diamantopoulou, the study’s first author and a molecular oncology researcher at ETH Zurich.

This paper was published in Nature.

 

Read original article here

The metastatic spread of breast cancer accelerates during sleep

  • Pantel, K. & Speicher, M. R. The biology of circulating tumor cells. Oncogene 35, 1216–1224 (2016).

    CAS 
    Article 

    Google Scholar 

  • Alix-Panabières, C. & Pantel, K. Circulating tumor cells: liquid biopsy of cancer. Clin. Chem. 59, 110–118 (2013).

    Article 

    Google Scholar 

  • Li, S. et al. Less micrometastatic risk related to circulating tumor cells after endoscopic breast cancer surgery compared to open surgery. BMC Cancer 19, 1070 (2019).

    Article 

    Google Scholar 

  • Zhu, X. et al. In vivo flow cytometry reveals a circadian rhythm of circulating tumor cells. Light Sci. Appl. 10, 110 (2021).

    ADS 
    CAS 
    Article 

    Google Scholar 

  • Szczerba, B. M. et al. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature 566, 553–557 (2019).

    ADS 
    CAS 
    Article 

    Google Scholar 

  • Ripperger, J. A., Jud, C. & Albrecht, U. The daily rhythm of mice. FEBS Lett. 585, 1384–1392 (2011).

    CAS 
    Article 

    Google Scholar 

  • Aceto, N. et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158, 1110–1122 (2014).

    CAS 
    Article 

    Google Scholar 

  • Sasportas, L. S. & Gambhir, S. S. Imaging circulating tumor cells in freely moving awake small animals using a miniaturized intravital microscope. PLoS ONE 9, e86759 (2014).

    ADS 
    Article 

    Google Scholar 

  • Papagiannakopoulos, T. et al. Circadian rhythm disruption promotes lung tumorigenesis. Cell Metab. 24, 324–331 (2016).

    CAS 
    Article 

    Google Scholar 

  • Bunger, M. K. et al. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell 103, 1009–1017 (2000).

    CAS 
    Article 

    Google Scholar 

  • Macaulay, I. C. et al. Separation and parallel sequencing of the genomes and transcriptomes of single cells using G&T-seq. Nat. Protoc. 11, 2081–2103 (2016).

    CAS 
    Article 

    Google Scholar 

  • Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat. Protoc. 9, 171–181 (2014).

    CAS 
    Article 

    Google Scholar 

  • Polymenis, M. & Aramayo, R. Translate to divide: сontrol of the cell cycle by protein synthesis. Microb. Cell 2, 94–104 (2015).

    CAS 
    Article 

    Google Scholar 

  • Masri, S. & Sassone-Corsi, P. The emerging link between cancer, metabolism, and circadian rhythms. Nat. Med. 24, 1795–1803 (2018).

    CAS 
    Article 

    Google Scholar 

  • Kettner, N. M., Katchy, C. A. & Fu, L. Circadian gene variants in cancer. Ann. Med. 46, 208–220 (2014).

    CAS 
    Article 

    Google Scholar 

  • Ikeda, Y., Kumagai, H., Skach, A., Sato, M. & Yanagisawa, M. Modulation of circadian glucocorticoid oscillation via adrenal opioid-CXCR7 signaling alters emotional behavior. Cell 155, 1323–1336 (2013).

    CAS 
    Article 

    Google Scholar 

  • Lucas, L. A. & Eleftheriou, B. E. Circadian variation in concentrations of testosterone in the plasma of male mice: a difference between BALB/cBy and C57BL/6By inbred strains. J. Endocrinol. 87, 37–46 (1980).

    CAS 
    Article 

    Google Scholar 

  • Hill, D. J. & Milner, R. D. Insulin as a growth factor. Pediatr. Res. 19, 879–886 (1985).

    CAS 
    Article 

    Google Scholar 

  • Crosby, P. et al. Insulin/IGF-1 drives PERIOD synthesis to entrain circadian rhythms with feeding time. Cell 177, 896–909 (2019).

    CAS 
    Article 

    Google Scholar 

  • Van Dycke, K. C. G. et al. Chronically alternating light cycles increase breast cancer risk in mice. Curr. Biol. 25, 1932–1937 (2015).

    Article 

    Google Scholar 

  • Blakeman, V., Williams, J. L., Meng, Q.-J. & Streuli, C. H. Circadian clocks and breast cancer. Breast Cancer Res. 18, 89 (2016).

    Article 

    Google Scholar 

  • Zomer, A. et al. In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior. Cell 161, 1046–1057 (2015).

    CAS 
    Article 

    Google Scholar 

  • van Rheenen, J. & Scheele, C. L. G. J. Intravital microscopy to illuminate cell state plasticity during metastasis. Curr. Opin. Cell Biol. 72, 28–35 (2021).

    Article 

    Google Scholar 

  • Kienast, Y. et al. Real-time imaging reveals the single steps of brain metastasis formation. Nat. Med. 16, 116–122 (2010).

    CAS 
    Article 

    Google Scholar 

  • Yu, M. et al. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science 345, 216–220 (2014).

    ADS 
    CAS 
    Article 

    Google Scholar 

  • Jones, M. T., Hillhouse, E. W. & Burden, J. L. Dynamics and mechanics of corticosteroid feedback at the hypothalamus and anterior pituitary gland. J. Endocrinol. 73, 405–417 (1977).

    CAS 
    Article 

    Google Scholar 

  • Read original article here

    Unlocking the Mystery of Why a Plant Virus Is So Powerful at Fighting Cancer – Even Metastatic Cancer

    Veronique Beiss, who is the study’s first author, prepares a tray of plants to produce cowpea mosaic virus nanoparticles. Credit: David Baillot/UC San Diego Jacobs School of Engineering

    Cowpea mosaic virus, a plant virus that infects legumes, has a special power that you may not be aware of: when injected into a tumor, it activates the immune system to treat the cancer—even metastatic cancer—and prevent it from returning.

    Researchers at the University of California San Diego and Dartmouth College have spent the last seven years studying and testing cowpea mosaic virus—in the form of nanoparticles—as a cancer immunotherapy and have reported encouraging results in lab mice and companion dog patients. Its effectiveness has been unrivaled by other cancer-fighting techniques examined by the researchers. However, the precise reasons for its effectiveness have remained a mystery.

    In a recent research study published in the journal Molecular Pharmaceutics, the researchers uncover details that explain why cowpea mosaic virus in particular is extraordinarily effective against cancer.

    The beauty of this approach is that it not only takes care of that one tumor, but it also launches a systemic immune response against any metastatic and future tumors.

    The work was led by Nicole Steinmetz, a professor of nanoengineering at the UC San Diego Jacobs School of Engineering, and Steven Fiering, a professor of microbiology and immunology at the Geisel School of Medicine at Dartmouth. Steinmetz and Fiering are co-founders of a biotechnology startup, called Mosaic ImmunoEngineering Inc., which has licensed the cowpea mosaic virus nanotechnology and is working to translate it into the clinic as a cancer immunotherapy.

    “This study helps validate the cowpea mosaic plant virus nanoparticle as our lead cancer immunotherapy candidate,” said Steinmetz, who also serves as the director of the Center for NanoImmunoEngineering at UC San Diego. “Now we have mechanistic data to explain why it is the most potent candidate, which further de-risks it for clinical translation.”

    Up until now, Steinmetz, Fiering and their teams had a general idea of how their lead candidate worked. The cowpea mosaic virus nanoparticles, which are infectious in plants but not in mammals, are injected directly inside a tumor to serve as immune system bait. The body’s immune cells recognize the virus nanoparticles as foreign agents and get fired up to attack. When the immune cells see that the virus nanoparticles are inside a tumor, they go after the cancerous cells.

    The beauty of this approach, noted Steinmetz, is that it not only takes care of that one tumor, but it also launches a systemic immune response against any metastatic and future tumors. The researchers have seen it work in mouse models of melanoma, ovarian cancer, breast cancer, colon cancer, and glioma. They’ve also had success using it to treat canine patients with melanoma, breast cancer, and sarcoma.

    What’s also interesting is that cowpea mosaic virus has worked the best at triggering an anti-cancer immune response compared to other plant viruses or virus-like particles the researchers have studied. “We’ve shown that it works, and now we need to show what makes it so special that it can induce this kind of response,” said first author Veronique Beiss, a former postdoctoral researcher in Steinmetz’s lab. “That’s the knowledge gap we’re looking to fill.”

    To get answers, the researchers compared cowpea mosaic virus with two other plant viruses from the same family that have the same shape and size. One virus, cowpea severe mosaic virus, shares a similar

    Read original article here

    The Ultimate News Site